Who cannot take nattokinase?

The people most likely to search for nattokinase are often the exact people who should not take it.

A single 2,000 FU dose measurably shifts coagulation markers within hours, which is precisely why several groups need to avoid it. Documented cases include a mechanical heart valve patient who developed valve thrombus after substituting nattokinase for warfarin for roughly a year [2].

This guide covers the eight groups who cannot take nattokinase, the grey-zone cases needing medical clearance first, and the allergy risk most articles miss entirely.

Table of Contents

1. Why Nattokinase Has an Exclusion List at All
2. Who Cannot Take Nattokinase: 8 Exclusions in Four Tiers
3. The Grey Zone: Who Needs Medical Clearance First
4. Surgery and Dental Work: The Two-Week Rule
5. The Allergy Exclusion Most People Get Wrong
6. What the Safety Research Covers — and What It Leaves Out
7. If You Are Not on the List: What to Check Before You Buy
8. Frequently Asked Questions
9. Conclusion
10. Research References

1. Why Nattokinase Has an Exclusion List at All

Nattokinase is a serine protease enzyme produced during the fermentation of soybeans with Bacillus subtilis. Its defining action is fibrinolysis — the breakdown of fibrin, the protein scaffold that holds a blood clot together. That is the whole reason people take it, and it is also the whole reason some people cannot.

The effect is not theoretical. In a double-blind, placebo-controlled crossover study, 12 healthy young men each received a single 2,000 FU dose. Researchers measured significant changes across five coagulation and fibrinolysis parameters [3]: D-dimer rose at 6 and 8 hours, fibrin degradation products rose at 4 hours, Factor VIII activity fell at 4 and 6 hours, antithrombin rose at 2 and 4 hours, and activated partial thromboplastin time lengthened at 2 and 4 hours.

Every one of those changes stayed inside the normal laboratory range. That detail is the hinge of this entire article. In a healthy adult, the shift is real but contained — the body has margin to absorb it. In someone whose clotting is already pushed toward bleeding by medication, a bleeding disorder, or a fragile blood vessel, that margin is already spent.

So the exclusion list is not built on the idea that nattokinase is a dangerous compound. It is built on who has room to absorb its effect and who does not.

2. Who Cannot Take Nattokinase: 8 Exclusions in Four Tiers

The following groups should not take nattokinase without explicit direction from the physician managing their care. This list reflects the guidance published by Memorial Sloan Kettering's integrative medicine service [7] and the clinical monograph maintained by Drugs.com [8].

What you should actually do differs between them, so they are grouped below by the action each one calls for.

Tier 1 — Do not take unless the physician managing your care directs it

• Anyone taking a prescription anticoagulant. This includes warfarin, apixaban, rivaroxaban, dabigatran, and heparin. The effects are additive, and no systematic data exist on nattokinase combined with the newer direct oral anticoagulants.
• Anyone on daily antiplatelet therapy. Aspirin and clopidogrel both raise bleeding risk on their own. The 2008 case that anchors this concern involved 400 mg/day of nattokinase taken alongside aspirin for just 7 days [1].
• Anyone with a mechanical heart valve. Nattokinase cannot substitute for warfarin in this setting. The one documented attempt ended in valve thrombus and a repeat operation.
• Anyone with a bleeding disorder, low platelet count, or active bleeding. Haemophilia and thrombocytopenia leave no reserve for an additional fibrinolytic push.
• Anyone with a history of haemorrhagic stroke, cerebral microbleeds, or peptic ulcer. These represent existing fragile sites where a bleed can start or restart.

Tier 2 — Pause, then resume

• Anyone with surgery or a dental procedure scheduled within two weeks. See Section 4.

Tier 3 — No safety data, so avoid

• Anyone pregnant or breastfeeding. There is no reliable human safety data in either population, and no teratogenicity or obstetric outcome studies exist.

Tier 4 — The allergy exclusion most people miss

• Anyone with a history of reaction to natto or fermented soybeans. See Section 5 — this exclusion is more commonly missed than any other on the list.

One further caution sits slightly outside the eight. Because nattokinase acts on established clots, an existing clot burden is a reason for caution rather than reassurance: Memorial Sloan Kettering directs anyone already undergoing anticoagulant, fibrinolytic, or antithrombotic treatment to avoid it [7], which covers most people being actively managed for deep vein thrombosis. That decision belongs to the treating physician, not to self-assessment.

3. The Grey Zone: Who Needs Medical Clearance First

Not everyone with a complication falls into an outright exclusion. Several situations call for a conversation with a physician rather than an automatic no.

People taking blood pressure medication. Nattokinase carries a moderate interaction rating with antihypertensive drugs [9] because the effects can stack. If you already take an ACE inhibitor, calcium channel blocker, or diuretic, adding nattokinase may push blood pressure lower than intended — a manageable issue if your prescriber knows about it, and an avoidable one if they do not.

People stacking other fibrinolytic or blood-thinning supplements. Serrapeptase, high-dose fish oil, ginkgo, and high-dose vitamin E all nudge the same system. The published caution applies to the combined load, not to any single product.

Older adults on multiple medications. The one fatal case in the literature involved an elderly woman taking over-the-counter nattokinase for atrial fibrillation while on no other anticoagulant [7]. Age itself is not a contraindication, but polypharmacy and undiagnosed vascular fragility raise the stakes considerably.

The common thread is disclosure. Supplement use is frequently not volunteered and not asked about, and that gap is where most of the documented harm in this literature originated.

4. Surgery and Dental Work: The Two-Week Rule

Nattokinase should be discontinued at least two weeks before any scheduled surgery [9]. The clinical monograph maintained by Drugs.com goes further, advising against use both before and after surgical procedures.

Two weeks is not an arbitrary buffer. The single-dose study showed effects on aPTT and Factor VIII within 2 to 6 hours of one capsule [3], and a two-week washout allows for accumulated effect, individual variation in clearance, and the possibility that a procedure gets moved forward.

The rule is not limited to major operations. Dental extractions, biopsies, colonoscopies with polyp removal, and cosmetic procedures all involve controlled bleeding that a surgeon or dentist is managing on the assumption of normal clotting.

Practical guidance: tell the surgical team you take it, using the words "nattokinase, a fibrinolytic enzyme supplement." Many intake forms ask only about medications, and supplements go unreported as a result. If your procedure is sooner than two weeks away, stop now and disclose it — do not quietly continue and hope the timing works out.

5. The Allergy Exclusion Most People Get Wrong

Most articles reduce this to a single line: avoid nattokinase if you are allergic to soy. That advice is incomplete in both directions, and the details matter.

The allergen implicated in natto reactions is not soy protein. Skin prick testing in a documented case pointed to poly-gamma-glutamic acid (PGA), a by-product of the fermentation process [5], which tested positive alone among all the ingredients the patient had consumed. A 38-year-old man in that report developed anaphylaxis with generalised urticaria and breathing difficulty roughly 3 hours after eating a food containing PGA.

Two consequences follow. First, tolerating tofu, soy milk, or edamame tells you nothing reliable about how you will respond to a natto-derived product. Second, sensitisation can happen without ever eating natto at all — PGA is also found in jellyfish nematocysts, and researchers have identified surfing as a route to sensitisation through repeated stings [6].

The timing is the most dangerous part. Natto-related anaphylaxis is characteristically late-onset, with symptoms appearing 4 to 15 hours after ingestion rather than within minutes. A reaction that arrives half a day later is easily attributed to something else entirely, which means the trigger can go unidentified across several episodes.

Anyone with a documented history of reaction to natto or fermented soybeans should avoid nattokinase supplements, including highly purified ones.

6. What the Safety Research Covers — and What It Leaves Out

Nattokinase has a reassuring safety record in clinical trials, and it is worth being precise about what that record does and does not cover.

The largest and longest study is the Nattokinase Atherothrombotic Prevention Study, which randomised 265 adults of median age 65.3 years to 2,000 FU or placebo for a median of 3 years [4]. It found no significant effect on carotid intima-media thickness, arterial stiffness, blood pressure, or any laboratory measure — a null result on efficacy, and no safety signal either.

Here is the limitation that matters for this article. That trial enrolled people without clinical evidence of cardiovascular disease. So did most of the others. The populations excluded from these trials are, almost exactly, the populations listed in Section 2 above. The reassurance applies to healthy adults; it was never tested on the people who most need to know.

What exists instead for high-risk groups is a small set of case reports — the 2008 cerebellar hemorrhage and the 2015 valve thrombosis described above, together with the fatal bleed noted in Section 3. Individual case reports cannot establish causation, and no published case series has systematically tracked nattokinase-associated bleeding. That is a genuine gap in the evidence, and it should be read as unresolved rather than as an all-clear.

7. If You Are Not on the List: What to Check Before You Buy

If none of the eight exclusions apply to you and your physician has no objection, the remaining question is one of product quality — and in an unregulated category, that varies more than most buyers expect.

Four things are worth verifying on any nattokinase product, regardless of brand. First, confirmed enzyme activity: nattokinase is dosed in fibrinolytic units, not milligrams, and potency degrades with poor handling. Look for batch testing that verifies the stated FU. Second, the capsule technology — the enzyme is stomach-acid sensitive, and many products use enteric coatings containing phthalates and plasticizers. Third, the allergen profile, which matters more here than in most supplement categories. Fourth, whether the formula includes vitamin K2, which some people are already supplementing separately.

The BioAbsorb Nattokinase Enzyme was built against those four criteria: 100 mg delivering 2,000 FU per capsule with every batch third-party tested to confirm at least 2,000 FU alongside screening for heavy metals, gluten, and microbial contaminants; a DRcaps delayed-release veggie capsule rather than a phthalate-coated enteric shell; a formulation free of gluten, nuts, eggs, dairy, fish, shellfish, and all animal products; and no added vitamin K2. It is manufactured in a GMP-certified Canadian facility and taken as a single capsule daily on an empty stomach.

None of that changes the exclusion list. A well-made product is still the wrong product for someone on warfarin.

Frequently Asked Questions

Can I take nattokinase if I only take a low-dose 81 mg aspirin?

This is a physician decision, not a self-assessment. Low-dose aspirin for cardiovascular prevention is a different risk profile from full-dose antiplatelet therapy, but the 2008 cerebellar hemorrhage case involved a patient on aspirin for secondary stroke prevention who had underlying cerebral microbleeds — a vulnerability that produces no symptoms and is only visible on MRI. Ask the prescriber who put you on aspirin.

How long before surgery do I need to stop taking nattokinase?

At least two weeks [9], and the same window applies to dental extractions, biopsies, and colonoscopies with polyp removal. If your procedure is closer than that, stop now and tell the surgical or dental team specifically that you have been taking a fibrinolytic enzyme supplement.

I am not allergic to soy — does that mean natto allergy is not a concern?

No. The allergen identified in natto reactions is poly-gamma-glutamic acid, a fermentation by-product, rather than soy protein — so tolerating tofu or soy milk does not predict your response. Sensitisation can also occur through jellyfish stings [6], meaning some people react without any prior natto exposure.

Can nattokinase replace my prescription blood thinner?

No, and the one documented attempt makes the case plainly: a patient with a mechanical aortic valve substituted nattokinase for warfarin, and after roughly a year developed thrombus on the valve requiring a repeat replacement [2]. The authors explicitly discourage the practice. Nattokinase has never been tested as an anticoagulant substitute in any controlled trial.

Is nattokinase safe during pregnancy or breastfeeding?

There is not enough reliable safety information in either population, and no teratogenicity or obstetric outcome studies have been published. The standard guidance is to avoid it, and that guidance reflects an absence of data rather than evidence of harm.

What symptoms mean I should stop taking nattokinase?

Unusual bruising, bleeding gums, nosebleeds, blood in urine or stool, or bleeding that takes longer than normal to stop all warrant stopping and contacting a physician. Delayed skin flushing, hives, or breathing difficulty appearing several hours after a dose may indicate a natto allergy, given the characteristic 4-to-15-hour onset window.

What if I have already been taking nattokinase and I am in one of these groups?

Stop, and tell the physician managing your care, including how long you have been taking it and at what dose. Don't wait for symptoms. Most people in this position come to no harm, but these exclusions exist because the consequences when it does go wrong are serious, and your physician needs that information. If you notice unusual bruising or bleeding in the meantime, seek medical advice promptly.

If none of these exclusions apply to me, will nattokinase work for me?

Not necessarily. Being outside the exclusion list means nattokinase is unlikely to harm you; it says nothing about whether it will help. The evidence for its benefits is modest and mixed, and many people notice no difference. Section 7 covers what to check before you buy, so that you are at least taking a product that matches the doses studied.

Conclusion

Nattokinase is well tolerated by healthy adults, but the trials that established that record — including the 265-participant, 3-year NAPS study [4] — deliberately excluded the people covered by the eight exclusions above. If you fall into one of those groups, the honest answer is that the evidence does not cover you and the case reports that do are not encouraging. If you do not, and your physician agrees, the BioAbsorb Nattokinase Enzyme delivers a batch-verified 2,000 FU in a phthalate-free delayed-release capsule.

Research References

1. Cerebellar Hemorrhage Provoked by Combined Use of Nattokinase and Aspirin in a Patient with Cerebral Microbleeds. Internal Medicine, Vol. 47, No. 5 (2008), pp. 467–469. Documented an acute cerebellar hemorrhage after seven consecutive days of nattokinase at 400 mg/day in a patient taking aspirin with pre-existing cerebral microbleeds, supporting the antiplatelet and haemorrhagic-history exclusions.
2. Consequence of Patient Substitution of Nattokinase for Warfarin After Aortic Valve Replacement with a Mechanical Prosthesis. Proceedings (Baylor University Medical Center), Vol. 28, No. 1 (2015), pp. 81–82. Reported valve thrombus requiring repeat replacement after approximately one year of self-substitution, establishing the mechanical heart valve exclusion.
3. A Single-Dose of Oral Nattokinase Potentiates Thrombolysis and Anti-Coagulation Profiles. Scientific Reports, Vol. 5, Art. 11601 (2015). Double-blind crossover in 12 healthy men showing that a single 2,000 FU dose measurably altered D-dimer, fibrin degradation products, Factor VIII, antithrombin, and aPTT within 2 to 8 hours, with all values remaining within normal range.
4. Nattokinase Atherothrombotic Prevention Study (NAPS): A Randomized Controlled Trial. Clinical Hemorheology and Microcirculation, Vol. 78, No. 4 (2021), pp. 339–353. Randomised 265 adults without clinical cardiovascular disease to 2,000 FU or placebo for a median of three years, finding no significant effect on any measured outcome — and enrolling none of the high-risk groups covered in this article.
5. Late-Onset Anaphylaxis Due to Poly (γ-glutamic acid) in the Soup of Commercial Cold Chinese Noodles in a Patient with Allergy to Fermented Soybeans (Natto). Allergology International, Vol. 60, No. 3 (2011), pp. 393–396. Identified poly-gamma-glutamic acid, a fermentation by-product, rather than soy protein as the relevant allergen in natto-induced anaphylaxis.
6. Surfing as a Risk Factor for Sensitization to Poly(γ-glutamic acid) in Fermented Soybeans, Natto, Allergy. Allergology International, Vol. 67, No. 3 (2018), pp. 341–346. Demonstrated that epicutaneous sensitisation to PGA can occur through jellyfish stings, explaining reactions in people with no prior natto exposure.
7. Nattokinase — About Herbs. Memorial Sloan Kettering Cancer Center. Clinical monograph stating that patients with coagulation disorders or on anticoagulant, fibrinolytic, or antithrombotic therapy should avoid nattokinase, and documenting a fatal internal bleed in an elderly patient using it for atrial fibrillation.
8. Nattokinase — Professional Natural Products Monograph. Drugs.com. Advises against use in ischemic stroke, peptic ulcer, and coagulation disorders, with concomitant anticoagulant therapy, and before or after surgery; also documents the 4-to-15-hour onset window for natto-related anaphylaxis.
9. Nattokinase — Uses, Side Effects, Precautions, Interactions, Dosing. RxList (Natural Medicines Comprehensive Database). Source of the two-week pre-surgical discontinuation guidance, the pregnancy and breastfeeding cautions, and the moderate interaction ratings with antihypertensive and anticoagulant medications.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.